title: Teratoma formation of human embryonic stem cells in three-dimensional perfusion culture bioreactors.
abstract: Teratoma formation in mice is today the most stringent test for pluripotency that is available for human pluripotent cells, as chimera formation and tetraploid complementation cannot be performed with human cells. The teratoma assay could also be applied for assessing the safety of human pluripotent cell-derived cell populations intended for therapeutic applications. In our study we examined the spontaneous differentiation behaviour of human embryonic stem cells (hESCs) in a perfused 3D multi-compartment bioreactor system and compared it with differentiation of hESCs and human induced pluripotent cells (hiPSCs) cultured in vitro as embryoid bodies and in vivo in an experimental mouse model of teratoma formation. Results from biochemical, histological/immunohistological and ultrastuctural analyses revealed that hESCs cultured in bioreactors formed tissue-like structures containing derivatives of all three germ layers. Comparison with embryoid bodies and the teratomas revealed a high degree of similarity of the tissues formed in the bioreactor to these in the teratomas at the histological as well as transcriptional level, as detected by comparative whole-genome RNA expression profiling. The 3D culture system represents a novel in vitro model that permits stable long-term cultivation, spontaneous multi-lineage differentiation and tissue formation of pluripotent cells that is comparable to in vivo differentiation. Such a model is of interest, e.g. for the development of novel cell differentiation strategies. In addition, the 3D in vitro model could be used for teratoma studies and pluripotency assays in a fully defined, controlled environment, alternatively to in vivo mouse models.
authors.affiliation: Berlin-Brandenburg Center for Regenerative Therapies, Charité-Universitätsmedizin, Berlin, Germany. Stachelscheid@charite.de
authors.forename: H
authors.initials: H
authors.lastname: Stachelscheid
authors.forename: A
authors.initials: A
authors.lastname: Wulf-Goldenberg
authors.forename: K
authors.initials: K
authors.lastname: Eckert
authors.forename: J
authors.initials: J
authors.lastname: Jensen
authors.forename: J
authors.initials: J
authors.lastname: Edsbagge
authors.forename: P
authors.initials: P
authors.lastname: Björquist
authors.forename: M
authors.initials: M
authors.lastname: Rivero
authors.forename: R
authors.initials: R
authors.lastname: Strehl
authors.forename: J
authors.initials: J
authors.lastname: Jozefczuk
authors.forename: A
authors.initials: A
authors.lastname: Prigione
authors.forename: J
authors.initials: J
authors.lastname: Adjaye
authors.forename: T
authors.initials: T
authors.lastname: Urbaniak
authors.forename: P
authors.initials: P
authors.lastname: Bussmann
authors.forename: K
authors.initials: K
authors.lastname: Zeilinger
authors.forename: J C
authors.initials: JC
authors.lastname: Gerlach
mesh_terms: D000818:Animals; D019149:Bioreactors; D018929:Cell Culture Techniques / Q000379:methods*; D002454:Cell Differentiation; D018920:Coculture Techniques / Q000379:methods*; D058732:Embryoid Bodies / Q000166:cytology*; D053595:Embryonic Stem Cells / Q000166:cytology*; D004867:Equipment Design; D020869:Gene Expression Profiling; D005855:Germ Layers / Q000378:metabolism; D006801:Humans; D021621:Imaging, Three-Dimensional; D057026:Induced Pluripotent Stem Cells / Q000166:cytology*; D051379:Mice; D016688:Mice, Inbred NOD; D016513:Mice, SCID; D010477:Perfusion; D039904:Pluripotent Stem Cells / Q000166:cytology; D013724:Teratoma / Q000473:pathology*